Results 91 to 100 of about 61,391 (245)

What's in the pipeline for pediatric headache treatment?

Headache: The Journal of Head and Face Pain, EarlyView.
Amy A. Gelfand, Christina L. Szperka
wiley   +1 more source

Immunoreactivity for CD34, Desmin, Keratins, KIT, Alpha‐Smooth Muscle Actin, S100, and Vimentin in Malignant Mesenchymal Neoplasms in Guinea Pigs: A Series of 62 Cases From a Single Institution

Veterinary Medicine and Science, Volume 12, Issue 2, March 2026.
Immunohistochemical expression of CD34, desmin, keratin AE1/AE3, keratin 8/18, KIT, SMA, S100, and vimentin in normal guinea pig skin serving as both positive and negative external tissue control. All images immunohistochemical staining, 200× magnification, scale bar 100 µm. (A) CD34 stained only vascular endothelium (arrow).
Jiří Lenz, Miša Škorič, František Tichý, Luděk Fiala   +3 more
wiley   +1 more source

The HRAS Variant c.175G>A (p.Ala59Thr) Causes a Predominantly Ectodermal Phenotype Lacking Classic Costello Syndrome Features

American Journal of Medical Genetics Part A, Volume 200, Issue 2, Page 407-418, February 2026.
ABSTRACT Costello syndrome (CS) is a rare dominant HRAS RASopathy characterized by curly hair, cardiac abnormalities, craniofacial anomalies, and developmental delay. HRAS codon 58, 59, and 60 variants are associated with milder phenotypes. We describe a three‐generation family with a previously unreported heterozygous HRAS variant c.175G>A (p.Ala59Thr)
Nikole Rautiainen, Eveliina Brandt, Kaisa Kettunen, Outi Elomaa, Sirpa Kivirikko, Leila Jeskanen, Katriina Lappalainen, Nelli Sjöblom, Juha Kere, Katariina Hannula‐Jouppi, Liisa Harjama   +10 more
wiley   +1 more source

HEMANGIOMAS

Annals of Surgery, 1953
J B, BROWN, M P, FRYER, F, MCDOWELL
openaire   +3 more sources

Efficacy of Topical Beta‐Blockers in Managing Epidermal Growth Factor Receptor Inhibitor‐Related Paronychia and Pyogenic Granuloma‐Like Lesion: A Systematic Review and Meta‐Analysis

Cancer Medicine, Volume 15, Issue 2, February 2026.
The meta‐analysis, involving with 96 patients, shows high overall response rate with favorable safety to use topical beta‐blockers for epidermal growth factor receptor inhibitors‐induced periungual side effects. Subgroups of lung cancer or solution formation had lower complete response rate, while tyrosine kinase inhibitor and female patients had ...
Po‐Kai Chan, Wei‐Ting Yen, Po‐Huang Chen   +2 more
wiley   +1 more source

Corrigendum to: Efficacy and safety of sclerosants in the treatment of venous malformations: A network meta-analysis of randomized controlled trials

Chinese Journal of Plastic and Reconstructive Surgery, 2022
Wei Lu, Zhenyu Yang, Zuoliang Qi, Xiaonan Yang   +3 more
doaj   +1 more source

Intranodal Hemangioma: Case Report and Systematic Review

Journal of Indian Association of Pediatric Surgeons
Background: Intranodal hemangiomas are rare benign vascular tumors of the lymph nodes, often misdiagnosed as malignant lymphadenopathies due to their clinical and radiological features.
Bitesh Kumar, Kaushal Kulkarni, Dhua Anjan Kumar, Goel Prabudh, Yadav Devendra Kumar, Jain Vishesh, Agarwala Sandeep, Kaur Kavneet, Kandasamy Devasenathipathy   +8 more
doaj   +1 more source

Rare Case of Vallecular Hemangioma With Complete Regression in an Adult Patient

The Laryngoscope, Volume 136, Issue 2, Page 794-797, February 2026.
A rare case of spontaneous regression of a pedunculated vallecular hemangioma in a 55‐year‐old male is presented. Following an incisional biopsy, the lesion regressed completely within three weeks, confirmed by imaging and direct laryngoscopy. This case highlights an unusual clinical outcome and raises questions about the mechanisms underlying ...
Guilherme Reimann Agne, Gustavo Nunes Bento, Marcelo Belli, Camila Batista Rossi, Luciana Depiere Lanzarin, Daniel Cury Ogata, Renan Bezerra Lira, Leandro Luongo Matos, Luiz Paulo Kowalski   +8 more
wiley   +1 more source

Adenosine Deaminase Acting on RNA1 (ADAR1) Deficiency Promotes Proliferation of Hemangioma-Derived Endothelial Cells via PI3K/Akt/mTOR Pathway [PDF]

, 2023
Chaoqi Yin, Ruyi Tao, Kaixi Tan, Jianfei Zhang   +3 more
openalex   +1 more source

Comparing the Molecular Pharmacological Properties of Existing β‐Blockers to Determine the Theoretically Most “Ideal” Anti‐Cancer β‐Blocker

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT There is increasing evidence, from cellular, animal and human epidemiological studies, linking β‐blockers with reductions in cancer growth and metastasis. Propranolol is the most investigated β‐blocker for cancer; although as many different off‐patent β‐blockers exist, there is little commercial incentive to drive comparative clinical trials ...
Jillian G. Baker
wiley   +1 more source